The high cost of sickle cell gene therapies is pushing private insurers and Medicaid programs to develop new payment models.

Earnings have fallen but are still strong enough to meet CVS Health's dividend commitment. Management expects adjusted ...

CVS Health has named Ed DeVaney as president of its pharmacy benefit manager, CVS Caremark. | DeVaney has served as interim ...